Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Lancet Oncol. 2017 Sep 25;18(11):1467–1482. doi: 10.1016/S1470-2045(17)30566-1

Figure 4. Treatment effect on overall survival by biomarker subgroup.

Figure 4

Forest plot assessing treatment effect on overall survival by (A) MET expression level measured as extent of tumour cell membrane staining (%) at staining intensity of 1+ or greater, (B) MET expression level measured as maximum staining intensity score, and (C) MET gene amplification level. ECX=epirubicin, cisplatin, and capecitabine. NE=not estimable. SI=staining intensity.